Cargando…

A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma

Enhancer RNAs (eRNAs) are intergenic long noncoding RNAs (lncRNAs) participating in the development of malignant cancers via targeting cancer-associated genes and immune checkpoints. Immune infiltration of the tumor microenvironment was positively associated with overall survival (OS) in lung adenoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li, Zhou, Shao-quan, Zhou, Yu, Lu, Jia-xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115606/ https://www.ncbi.nlm.nih.gov/pubmed/35600050 http://dx.doi.org/10.1155/2022/8069858

Ejemplares similares

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Comprehensive transcriptomic analysis of immune-related eRNAs associated with prognosis and immune microenvironment in melanoma
por: Gan, Yuling, et al.
Publicado: (2022)

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma
por: Wu, Pu, et al.
Publicado: (2022)

Potential mechanisms and prognostic model of eRNAs-regulated genes in stomach adenocarcinoma
por: Gao, Liuying, et al.
Publicado: (2022)

A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer
por: Wang, Linbang, et al.
Publicado: (2021)

Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype
por: Qin, Na, et al.
Publicado: (2020)

A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Xuewen, et al.
Publicado: (2022)

Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects
por: Wan, Lilin, et al.
Publicado: (2022)

Exploring the potential of eRNAs in cancer immunotherapy
por: Luo, Lianxiang, et al.
Publicado: (2022)

Enhancer RNA (eRNA) in Human Diseases
por: Wang, Yunzhe, et al.
Publicado: (2022)

A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer
por: Fan, Shuaishuai, et al.
Publicado: (2021)

eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways
por: Ahmed, Ibrahim, et al.
Publicado: (2023)

Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme
por: Guo, Xiao-Yu, et al.
Publicado: (2021)

Systematic functional characterization of antisense eRNA of protocadherin α composite enhancer
por: Zhou, Yuxiao, et al.
Publicado: (2021)

Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades
por: Napoli, Sara, et al.
Publicado: (2022)

Revealing eRNA interactions: TF dependency and convergent cooperativity
por: Lee, Seungha Alisa, et al.
Publicado: (2023)

Reprogramming Transcription via Distinct Classes of Enhancers Functionally Defined by eRNA
por: Wang, Dong, et al.
Publicado: (2011)

An Inflammatory Response-Related Gene Signature Can Predict the Prognosis and Impact the Immune Status of Lung Adenocarcinoma
por: Shi, Yubo, et al.
Publicado: (2022)

eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer
por: Zhang, Xiaona, et al.
Publicado: (2020)

Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
por: Zhang, Zhao, et al.
Publicado: (2019)

Drug metabolism‐related eight‐gene signature can predict the prognosis of gastric adenocarcinoma
por: Yin, Hong‐mei, et al.
Publicado: (2021)

The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance
por: Hu, Xin, et al.
Publicado: (2022)

The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription
por: Mikhaylichenko, Olga, et al.
Publicado: (2018)

Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment
por: Ding, Mengting, et al.
Publicado: (2018)

eRNA co-expression network uncovers TF dependency and convergent cooperativity
por: Lee, Seungha Alisa, et al.
Publicado: (2023)

eRNAs Identify Immune Microenvironment Patterns and Provide a Novel Prognostic Tool in Acute Myeloid Leukemia
por: Jiang, Ziming, et al.
Publicado: (2022)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture
por: Kristjánsdóttir, Katla, et al.
Publicado: (2020)

Identification of Key eRNAs for Spinal Cord Injury by Integrated Multinomial Bioinformatics Analysis
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Festschrift für Erna Lesky zum 70. Geburtstag
por: Jarcho, Saul
Publicado: (1982)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

Chromatin looping and eRNA transcription precede the transcriptional activation of gene in the β-globin locus
por: Kim, Yea Woon, et al.
Publicado: (2015)

Global patterns of enhancer activity during sea urchin embryogenesis assessed by eRNA profiling
por: Khor, Jian Ming, et al.
Publicado: (2021)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

Identification of Inflammatory Response-Related Gene Signature Associated With Immune Status and Prognosis of Lung Adenocarcinoma
por: Zou, Weijie, et al.
Publicado: (2021)

Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma
por: Gong, Zetian, et al.
Publicado: (2022)

A necroptosis‐related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma
por: Chen, Junliang, et al.
Publicado: (2022)

Single-cell profiling reveals that eRNA accumulation at enhancer–promoter loops is not required to sustain transcription
por: Rahman, Samir, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sei9r2ofb0gqe01t3vdlv0bipn